Atypical Spindle Cell Mesenchymal Tumors: Malignant Potential Assessment
Diagnostic Challenges
- Atypical spindle cell mesenchymal tumors represent a morphologically diverse group of rare lesions that bear striking resemblance to both benign and malignant entities, making their classification particularly challenging 1
- These tumors occur most frequently in children and young adults, but can also affect middle-aged or older adults 2
- The exact biological potential of these tumors is controversial, with some cases demonstrating unexpected lymph nodal metastasis during long-term follow-up despite initially appearing benign 3
Diagnostic Algorithm
- Evaluate for concerning histological features associated with malignancy, including architectural features such as asymmetry, lack of circumscription, lack of maturation, and ulceration, as well as cytological features like deep dermal mitosis, frequent mitosis, and high-grade cytological atypia, and host response like brisk tumor-infiltrating lymphocytic infiltrates 3
- Perform a set of immunohistochemistry assays to assess malignant potential, including dual-color Ki67/MART-1 to identify deep dermal cell proliferation, p16Ink4a to detect complete loss of expression, and HMB45 to identify complete loss of expression 4, 3
Malignant vs. Benign Features
- Positive FISH for "melanoma pattern" of chromosomal aberrations suggests malignancy 3
- Isolated homozygous loss of 9p21, isolated gain of 6p25 or gain of 11q13, complete loss of p16 expression, deep dermal cell proliferation by Ki67/MART-1, and multiple high-risk histological features are associated with malignant behavior 3
- Retention of p16 expression, absence of chromosomal aberrations on FISH and array-based comparative genomic hybridization, well-circumscribed borders, and absence of deep dermal mitotic activity suggest benign behavior 3, 4
Management Approach
- Patients with suspected bone sarcomas should be referred to a specialized sarcoma center before biopsy is performed, according to the guidelines from a specialized medical society 6